The mechanisms of action of human synthetic and naturally secreted cell-derived amyloid ␤-peptide (A␤) 1-42 on the induction of long-term potentiation (LTP) were investigated in the medial perforant path to dentate granule cell synapses in hippocampal slices. 
Introduction
Excessive cerebral accumulation of the amyloid ␤-peptide (A␤), a cleavage product of the ␤-amyloid precursor protein (APP), has been strongly implicated as a causal factor in Alzheimer's disease (AD). A␤ can exist in a variety of different forms, including monomers, oligomers, protofibrils, and fibrils (Walsh et al., 1997; Bitan et al., 2003) . Fibrillar A␤ has been linked to the pathogenesis of AD for many years and is known to have neurotoxic properties (Lorenzo and Yankner, 1994) . However, recent studies have suggested a critical role for soluble diffusible forms of A␤ as key effectors of neuronal dysfunction in AD Walsh et al., 1999 Walsh et al., , 2002 Dahlgren et al., 2002; Selkoe, 2002; Kayed et al., 2003) .
There is now considerable evidence that AD represents a synaptic failure, and in particular, that A␤-induced dysfunction of synaptic plasticity contributes to early memory loss that precedes neuronal degeneration (Small et al., 2001; Selkoe, 2002) . A prominent form of synaptic plasticity is long-term potentiation (LTP), a sustained increase in excitatory synaptic transmission. Certain species of synthetic A␤, especially A␤ , acutely inhibit the induction of LTP in the hippocampus without affecting basal synaptic transmission (Cullen et al., 1997; Lambert et al., 1998; Itoh et al., 1999; Chen et al., 2000; Stephan et al., 2001; Vitolo et al., 2002) . In a recent study, we showed that LTP induction in the hippocampus in vivo was inhibited by a cell medium containing naturally secreted human A␤ oligomers but not monomers or fibrils (Walsh et al., 2002) . APP transgenic mice also have deficient LTP induction (Chapman et al., 1999; Seabrook et al., 1999) . The inhibition of LTP induction by A␤ may represent an early manifestation of AD and particularly its harbinger, minimal cognitive impairment (Cullen et al., 1997; Chapman et al., 1999; Selkoe, 2002) . This hypothesis is supported by studies showing that infused synthetic A␤ peptides have an acute amnestic action (Flood et al., 1991; Maurice et al., 1996) .
Little is known about the mechanisms involved in A␤-mediated inhibition of LTP. However, there is evidence that synthetic A␤ can activate certain kinases that are known to be activated in the AD brain, including c-Jun N-terminal kinase (JNK) (Shoji et al., 2000; Bozyczko-Coyne et al., 2001; Morishima et al., 2001; Troy et al., 2001; Zhu et al., 2001a) , p38 MAP kinase (MAPK) (McDonald et al., 1998; Pyo et al., 1998; Hensley et al., 1999; Zhu et al., 2001b) , and cyclin-dependent kinase 5 (Cdk5) (Alvarez et al., 1999; Patrick et al., 1999; Ahlijanian et al., 2000; Lee et al., 2000) . Activation of metabotropic glutamate receptors (mGluRs) may also be involved in A␤ toxicity, because the mGluR5 antagonist methyl-6-(phenylethynyl)pyridine (MPEP) is protective against such toxicity (Bruno et al., 2000) .
The aim of the present studies was twofold. First, we wanted to determine whether naturally secreted A␤ inhibited LTP induction in hippocampal slices and to compare the potency of naturally secreted and synthetic A␤. Second, to understand further the mechanisms underlying the inhibition of LTP induction by A␤, we examined the involvement of certain kinases and transmitter receptors, namely JNK, p38 MAPK, and Cdk5, as well as mGluRs.
Materials and Methods
Preparation of slices. All experiments were conducted on transverse slices of the rat hippocampus (males; 3-4 weeks of age; weight, 40 -80 gm). The brains were rapidly removed after decapitation and placed in cold oxygenated (95% O 2 , 5% CO 2 ) media. Slices were cut at a thickness of 350 m using a Campden Instruments (Lafayette, IN) vibroslice and placed in a storage container with oxygenated medium at room temperature (20 -22°C) for 1 hr. The slices were then transferred to a recording chamber for submerged slices and continuously superfused at a rate of 5-6 ml/min at 30 -32°C. The control media contained the following (in mM): 120 NaCl, 2.5 KCl, 1.25 NaH 2 PO 4 , 26 NaHCO 3 , 2.0 MgSO 4 , 2.0 CaCl 2 , and 10 D-glucose. All solutions contained 100 M picrotoxin (Sigma, St. Louis, MO) to block GABA A -mediated activity.
Agents. The following drugs were used: 2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene (U0126; Tocris Cookson, Ballwin, MO), synthetic human A␤ 1-42 (Bachem, Bubendorf, Switzerland), JNKI, roscovitine (Calbiochem, La Jolla, CA), butyrolactone (Affiniti Research Products, Exeter, Devon, UK), 4-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-5-(4-pyridyl)-1H-imidazole (SB203580), anthra[1,9-cd]pyrazol-6(2H)-one (SP600125; Alexis, Grünberg, Germany), methylcaconatine (MLA), and MPEP (Sigma). LY341495, U0126, roscovitine, SP600125, butyrolactone, and SB203580 were dissolved in DMSO, with a maximum final concentration of 0.1% DMSO. JNKI, MPEP, and MLA were prepared in distilled water. Synthetic A␤ 1-42 was prepared as a stock solution of 50 M in ammonium hydroxide (0.1%), stored at Ϫ20°C, and then added to physiological medium immediately before each experiment. The actual concentration of A␤ 1-42 from one batch of peptide was determined experimentally by quantitative amino acid analysis and found to be 33% lower than the nominal value.
Cell-derived and synthetic A␤. Naturally secreted cell-derived human A␤ was obtained from cultures of Chinese hamster ovary (CHO) cells stably expressing human APP751, containing the Val717Phe familial AD mutation called 7PA2 cells. CHO and 7PA2 cells were cultured in DMEM with 10% fetal bovine serum, as described previously (Walsh et al., 2000) . When confluent, the cells were washed with plain DMEM and then incubated in plain DMEM (4 ml/10 cm 2 dish) for 16 hr. At the end of this period, media were harvested and cleared of cells by centrifugation at 500 ϫ g for 10 min. Aliquots of the media were then removed, and the presence of both monomeric and oligomeric A␤ was assessed by immunoprecipitation-Western blotting (ip-wb) and ELISAs. ELISAs were performed as described previously (Walsh et al., 2000) . Thus, ELISAs for A␤1-total (all A␤ species beginning at Asp1) and A␤ 1-42 were performed using 3D6 (which recognizes the extreme N terminus of A␤) as the capture antibody and 6C6 (which binds to the midregion of A␤) for detection. In detail, nearly confluent (95-100%) 10 cm 2 dishes of 7PA2 cells and their corresponding untransfected parental CHO cell line were starved of methionine for 30 min and labeled with 750 Ci of [
35 S]methionine; their media were then harvested and immunoprecipitated. After electrophoresis on 16% tricine gels, bands were visualized by gel fluorography. For experiments examining the ability of A␤ oligomers to form in conditioned medium (CM) in the absence of cells, 7PA2 cells were pulsed with 1 mCi of [ 35 S]methionine for 2 hr. The labeled medium was harvested, cleared of cells, incubated at either 4 or 37°C for 15 hr in the presence or absence of CHO cells and then immunoprecipitated with the polyclonal antibody R1282. As positive controls, 7PA2 cells were labeled for 17 hr, and their CM was immunoprecipitated as described above. To visualize steady-state levels of A␤ in human CSF and in cultures that were not radiolabeled, we devised an ip-wb protocol that allowed the highly sensitive detection of unlabeled A␤ species. Analysis of CM by ELISA and ip-wb revealed that our ip-wb protocol can readily detect as little as 200 pg of endogenously secreted A␤. Samples were immunoprecipitated to avoid reconstitution procedures that might alter the assembly form or recovery of A␤. After immunoprecipitation, samples were electrophoresed on 16% tricine gels and transferred onto 0.2 M nitrocellulose membranes at 400 mA for 2 hr. Filters were boiled for 10 min in PBS and blocked overnight at 4°C with 5% fat-free milk in 20 mM Tris-HCl, pH 7.4, containing 150 mM NaCl and 0.05% Tween 20 (TBS-T). After washing the membranes in TBS-T, monoclonal antibody 6E10 or a combination of monoclonals 4G8 and 6C6 (each at 1 g/ml) was used to probe the blots. Bound antibody was visualized using horseradish peroxidase-conjugated anti-mouse Ig (at 1:40,000) (Jackson ImmunoResearch, West Grove, PA) and ECL Plus detection (Amersham Biosciences, Arlington Heights, IL).
Electrophysiological techniques. Standard electrophysiological techniques were used to record field potentials. Presynaptic stimulation was applied to the medial perforant pathway of the dentate gyrus using a bipolar insulated tungsten wire electrode, and field EPSPs were recorded at a control test frequency of 0.033 Hz from the middle one-third of the molecular layer of the dentate gyrus with a glass microelectrode. The outer blade of the dentate gyrus was used in all studies. In each experiment, an input-output curve (afferent stimulus intensity vs EPSP amplitude) was plotted at the test frequency. For all experiments, the amplitude of the test EPSP was adjusted to one-third of the maximum (ϳ1.2 mV). LTP was evoked by high-frequency stimulation (HFS) consisting of eight trains, eight of each stimuli at 200 Hz, and an intertrain interval of 2 sec, with the stimulation voltage increased during the HFS to elicit an initial EPSP of the train of double the normal test EPSP amplitude.
In experiments involving kinase inhibitors and receptor antagonists, the agents were preperfused over the slices for 60 min before HFS. Control (vehicle alone) and experimental levels of LTP were measured on slices prepared from the same hippocampus. In experiments involving kinase inhibitors, the effect of the kinase inhibitor alone and the effects of the kinase inhibitor applied together with A␤ were also assessed on slices from the same hippocampus.
Recordings were analyzed using pClamp software (Axon Instruments, Foster City, CA). Values are the means Ϯ SEM for n slices. A two-tailed Student's t test was used for statistical comparison.
Results

Synthetic and cell-derived A␤ inhibits induction of LTP in hippocampal slices
In rat hippocampal slices, HFS induced LTP under control conditions that reached a peak amplitude of ϳ100% above baseline immediately after HFS and then slowly declined over the next hour to 50 -80% above baseline. The averaged LTP Ϯ SEM measured 188 Ϯ 14, 155 Ϯ 10, and 151 Ϯ 6% at peak, 20 min after HFS, and 60 min after HFS, respectively ( p Ͻ 0.005; n ϭ 12) (Fig. 1 A) .
Both synthetic and cell-derived A␤ inhibited the induction of LTP, including the early and late phases of LTP. In the presence of synthetic A␤ 1-42 (500 nM) perfused for 60 min before HFS, LTP measured 148 Ϯ 12, 108 Ϯ 9, and 100 Ϯ 9% at peak, 20 min after HFS, and 60 min after HFS, respectively, with all three values significantly less than controls ( p Ͻ 0.005; n ϭ 8) (Fig. 1 A) . A two-way ANOVA comparing treatment with A␤ with time showed no significant interaction (F ϭ 2.5; p Ͻ 0.05), demonstrating a constant inhibition with time. Additional experiments were conducted on the effects of 500 nM A␤ on LTP induction throughout the course of the present study. Three to six interleaved control experiments on the effect of A␤ on LTP induction were performed during the investigation of the effect of each agent on the A␤-mediated block of LTP induction. These experiments showed an inhibitory effect of A␤ on LTP induction that was very similar to that seen for the initial set of controls, with LTP measuring 151 Ϯ 12, 112 Ϯ 8, and 100 Ϯ 7% at peak, 20 min after HFS, and 60 min after HFS, respectively; in the presence of A␤, all three values were significantly less than control LTP in the absence of A␤ ( p Ͻ 0.005; n ϭ 48) (data not shown). Synthetic A␤ (500 nM) did not alter baseline transmission, which measured 98 Ϯ 2% after 90 min of perfusion ( p Ͼ 0.05; n ϭ 4) ( Fig. 1 B) . A concentration of 200 nM synthetic A␤ also inhibited LTP induction, which measured 176 Ϯ 8, 131 Ϯ 6, and 115 Ϯ 7% at peak, 20 min after HFS, and 60 min after HFS, respectively ( p Ͻ 0.05; n ϭ 5) (data not shown). However, 100 nM A␤ did not significantly inhibit LTP induction, with LTP measuring 192 Ϯ 23, 155 Ϯ 18, and 146 Ϯ 10% at peak, 20 min after HFS, and 60 min after HFS, respectively ( p Ͼ 0.05; n ϭ 5) (data not shown).
Synthetic A␤ 1-42 assembles into a variety of structures in aqueous buffers, including low N-oligomers, A␤-derived diffusible neurotoxic soluble ligands (ADDLs), protofibrils, and fibrils (Walsh et al., 1997; Lambert et al., 1998; Bitan et al., 2003) . The solutions of synthetic A␤ used in this study contained a mixture of these assemblies. To determine whether soluble forms of A␤ contributed to the inhibition of LTP in vitro, we tested the effect of 7PA2 CM, which contains only A␤ monomer and low N-oligomers and is free of fibrils and protofibrils (Walsh et al., 2002) . Conditioned medium containing cell-derived A␤ was collected from 7PA2 cells. The concentration of A␤ peptide as measured by A␤1-total ELISA (see Materials and Methods) in serumfree conditioned medium ranged from 3 to 6 pg/ml, in agreement with that found in our previous studies (Walsh et al., 2000 (Walsh et al., , 2002 . CHO-CM, which does not contain human A␤, was used as a negative control (see Materials and Methods). All 7PA2 and CHO-CM samples were analyzed by immunoprecipitationWestern blotting and gave consistent results in which A␤ monomer and oligomers were detected in 7PA2 CM but absent in CHO-CM. The medium from the cell cultures was diluted with DMEM before perfusion onto the slices.
Control LTP in CHO-CM devoid of cell-derived A␤ was not significantly different from LTP in physiological medium, measuring 223 Ϯ 18, 192 Ϯ 13, and 188 Ϯ 10% at peak, 20 min after HFS, and 60 min after HFS, respectively (Fig. 1C) (n ϭ 5). However, in the presence of cell-derived naturally secreted A␤ diluted threefold in DMEM (measured A␤ concentration was 1.1 nM) and perfused for 60 min before HFS, LTP induction was inhib- ited, measuring 170 Ϯ 10, 127 Ϯ 6, and 110 Ϯ 7% at peak, 20 min after HFS, and 60 min after HFS, respectively. All three values were significantly less than control LTP in normal bath media or CHO-CM ( p Ͻ 0.005) (Fig. 1C) (n ϭ 5). Cell-derived A␤ diluted fivefold also inhibited LTP induction, although to a lesser extent than the threefold dilution, measuring 192 Ϯ 11, 153 Ϯ 5, and 135 Ϯ 7% at peak, 20 min after HFS, and 60 min after HFS, respectively (n ϭ 5; p Ͻ 0.01) (data not shown).
To investigate the effect of A␤ on the expression of LTP, synthetic A␤ was perfused immediately after HFS. The expression of LTP after a single HFS was not inhibited by A␤, with LTP measuring 163 Ϯ 8% at 60 min after HFS ( p Ͼ 0.05; n ϭ 4) (Fig. 1 D) .
The inhibition of LTP by synthetic and cell-derived A␤ is prevented by inhibitors of JNK
The JNK group of protein kinases is a subgroup of the MAP kinase family, which is known to be activated by cellular stresses, including synthetic A␤ (Bozyczko-Coyne et al., 2001; Morishima et al., 2001; Troy et al., 2001) . Activation of JNK occurs in the AD brain (Shoji et al., 2000; Zhu et al., 2001a) . To assess the involvement of JNK in the inhibitory effects of A␤ on LTP induction, two JNK inhibitors, JNKI and SP600125, were studied. The inhibitor JNKI, based on amino acids 143-163 of the JNK-binding domain of the JNK scaffolding protein JNK-interacting protein-1, has been shown to interact directly and inhibit JNK (IC 50 , ϳ0.5 M) but does not inhibit the activities of the related extracellular signal-regulated kinase (ERK) and p38 MAPKs (Bonny et al., 2001; Barr et al., 2002) .
LTP induction was not altered by JNKI (2 M) perfused alone, measuring 198 Ϯ 11, 150 Ϯ 4, and 138 Ϯ 9% at peak, 20 min after HFS, and 60 min after HFS, respectively (n ϭ 5; p Ͼ 0.05) (Fig.  2 A) . These values of LTP in JNKI are not significantly different from those of control LTP in the normal physiological medium. However, JNKI prevented the inhibition of LTP by synthetic A␤, with LTP measuring 178 Ϯ 12, 147 Ϯ 7, and 136 Ϯ 5% (n ϭ 6) at peak, 20 min after HFS, and 60 min after HFS, respectively, and values were significantly greater than the values of LTP induction in the presence of synthetic A␤ alone ( p Ͻ 0.01) and were not significantly different from control LTP ( p Ͼ 0.05) (Fig. 2A) . JNKI also prevented the inhibition of LTP induction by cell-derived A␤, with LTP measuring 200 Ϯ 14, 154 Ϯ 7, and 140 Ϯ 7% (n ϭ 5) at peak, 20 min after HFS, and 60 min after HFS, respectively; in the presence of JNKI, values were increased significantly compared with those in the presence of cell-derived A␤ alone ( p Ͻ 0.01) and were not significantly different from control LTP in CHO-CM ( p Ͼ 0.05) (Fig. 2B) (n ϭ 5).
To confirm these results, a second JNK inhibitor was examined. SP600125 is a potent (K i ϭ 0.19 M) ATP-competitive JNK inhibitor based on an anthrapyrazalone series with a Ͼ20-fold selectivity over a range of other kinases, including ERK, p38, PKA, and PKC (Bennett et al., 2001) . Perfused alone, SP600125 (20 M) did not significantly alter LTP induction, which measured 215 Ϯ 17, 176 Ϯ 10, and 161 Ϯ 5% at peak, 20 min after HFS, and 60 min after HFS, respectively (n ϭ 5; p Ͼ 0.05) (Fig.  2C) . LTP induction was also not altered by 0.1% DMSO alone, the vehicle used for SP600125 and certain other compounds (see Materials and Methods), with LTP measuring 203 Ϯ 11, 164 Ϯ 17, and 152 Ϯ 13% (n ϭ 5; p Ͼ 0.05) at peak, 20 min after HFS, and 60 min after HFS, respectively (data not shown). Similar to JNKI, SP600125 prevented the inhibition of LTP by synthetic A␤, with LTP measuring 180 Ϯ 6, 137 Ϯ 2, and 133 Ϯ 2% at peak, 20 min after HFS, and 60 min after HFS, respectively, and values were increased significantly compared with the values of LTP induction in the presence of synthetic A␤ alone (n ϭ 5; p Ͻ 0.05) (Fig. 2C) . However, at the concentration used (20 M), SP600125 did not completely reverse the inhibition of LTP by A␤, with the values of LTP induction in SP600125 and A␤ being significantly lower than in SP600125 alone ( p Ͻ 0.05).
The inhibition of LTP by synthetic A␤ is prevented by inhibitors of Cdk5
Cdk5 is a Ser-Thr kinase that has important general roles in phosphorylating cell cycle and cytoskeletal proteins. Activation of Cdk5 by binding to its regulatory subunit p35 to form the p35-Cdk5 complex is essential for neuronal development and plasticity (Dhavan and Tsai, 2001 ). There is compelling evidence that inhibition of the activity of Cdk is detrimental to survival of neurons (Nguyen et al., 2002) , and Cdk5 has been implicated in Alzheimer's pathology (Patrick et al., 1999; Ahlijanian et al., 2000) . To determine the involvement of Cdk5 in the inhibitory effects of A␤ on LTP induction, two inhibitors of Cdk5, butyrolactone and roscovitine, were studied. Butyrolactone and roscovitine are potent inhibitors of Cdk5, with IC 50 values of 0.49 M (Liu et al., 2001 ) and 0.16 M (Knockaert et al., 2002) , respectively.
Both butyrolactone and roscovitine reversed the inhibitory effect of synthetic A␤ on LTP induction. Butyrolactone alone, perfused 60 min before HFS, did not alter LTP induction, which measured 192 Ϯ 9, 160 Ϯ 7, and 147 Ϯ 9% at peak, 20 min after HFS, and 60 min after HFS, respectively, and values were not significantly different from control LTP (n ϭ 6; p Ͼ 0.01) (Fig. 3A) . However, butyrolactone prevented the inhibition of LTP induction by synthetic A␤. Thus, LTP induction measured 184 Ϯ 10, 145 Ϯ 6, and 136 Ϯ 6% at peak, 20 min after HFS, and 60 min after HFS, respectively; in the presence of butyrolactone, values were increased significantly compared with those in the presence of synthetic A␤ alone ( p Ͻ 0.05) and were not significantly different from control LTP (n ϭ 6; p Ͼ 0.05) (Fig. 3A) .
Roscovitine alone, perfused 60 min before HFS, did not alter LTP induction, which measured 194 Ϯ 20, 159 Ϯ 10, and 150 Ϯ 5% at peak, 20 min after HFS, and 60 min after HFS, respectively, and values were not significantly different from control LTP ( p Ͼ 0.01; n ϭ 6) (Fig. 3B) . However, roscovitine prevented the inhibition of LTP induction by synthetic A␤, with LTP induction measuring 176 Ϯ 16, 142 Ϯ 7, and 142 Ϯ 4% (n ϭ 6) at peak, 20 min after HFS, and 60 min after HFS, respectively, and values were increased significantly compared with the values of LTP induction in the presence of synthetic A␤ alone ( p Ͻ 0.05) and were not significantly different from LTP in roscovitine alone ( p Ͼ 0.05) (Fig. 3B) .
The inhibition of LTP by synthetic A␤ is prevented by inhibition of p38 MAP kinase but not p42-p44 MAP kinase p38 MAPK and p42-p44 MAPK are distinct subgroups of the MAP kinase family. The p38 MAPK subgroup is well known to be involved in inflammation and cell death (Ono and Han, 2000) , whereas p42-p44 MAPKs have been characterized extensively as a central component of signal transduction pathways stimulated by growth-related stimuli. To determine whether the inhibitory effects of A␤ on LTP induction are mediated via activation of p38 or p42-p44 MAPKs, the effect of applying synthetic A␤ in the presence of inhibitors of these kinases was determined. SB203580 is a highly selective p38 MAP kinase inhibitor with an IC 50 of 34 nM (Lee et al., 1994) . Applied alone, SB203580 (1 M) did not alter LTP induction, which measured 192 Ϯ 9, 160 Ϯ 7, and 147 Ϯ 9% at peak, 20 min after HFS, and 60 min after HFS, respectively, and values were not significantly different from control LTP (n ϭ 6; p Ͼ 0.005) (Fig. 3C) . However, SB203580 prevented the inhibition of LTP induction by synthetic A␤. Thus, LTP induction measured 184 Ϯ 10, 145 Ϯ 6, and 136 Ϯ 6% at peak, 20 min after HFS, and 60 min after HFS, respectively; in the presence of SB203580, values were increased significantly compared with the values of LTP induction in the presence of synthetic A␤ alone (n ϭ 6; p Ͻ 0.005) and were not significantly different from control LTP ( p Ͼ 0.05) (Fig. 3C) . The effect of inhibition of p42-p44 MAP kinase was investigated using the MAP kinase kinase (MEK) inhibitor U0126 (5 M). This concentration of U0126 is known to completely block both basal and stimulus-induced activation of p42-p44 MAP kinase in hippocampal slices (Roberson et al., 1999) . Applied alone, U0126 did not alter LTP induction, which measured 207 Ϯ 12, 172 Ϯ 13, and 146 Ϯ 7% at peak, 20 min after HFS, and 60 min after HFS, respectively, and values were not significantly different from those of control LTP induction (n ϭ 5; p Ͼ 0.05) (Fig. 3D) . Although LTP induced by a brief HFS in rat CA1 is inhibited by MEK inhibitors (Selcher et al., 2003) , we find that in the rat dentate gyrus, only LTP induced by prolonged stimulation is sensitive to MEK inhibitors (our unpublished observations), which parallels the situation found in mice (Winder et al., 1999; Watabe et al., 2000) , although LTP induced by prolonged stimulation is sensitive to such inhibitors (Winder et al., 1999; Watabe et al., 2000) . U0126 did not prevent the inhibition of LTP by A␤, with LTP measuring 152 Ϯ 12, 106 Ϯ 6, and 97 Ϯ 3% at peak, 20 min after HFS, and 60 min after HFS, respectively, and values were not significantly different from those in A␤ alone ( p Ͼ 0.05) (Fig. 3D) .
The inhibition of LTP by A␤ involves activation of mGluR5 but not the ␣7 nicotinic receptor
To identify whether the inhibitory action of A␤ on LTP induction is mediated via activation of the specific transmitter receptors mGluR5 or the ␣7 nicotinic ACh receptor (nAChR), synthetic A␤ was applied in the presence of selective antagonists of these receptors.
LY341495 has been shown to be a selective group I-group II mGluR antagonist (Fitzjohn et al., 1998; Kingston et al., 1998) . This antagonist does not inhibit the induction of LTP in CA1 (Fitzjohn et al., 1998) or, as determined in previous experiments from this laboratory, in the medial perforant path of the dentate gyrus (Rush et al., 2002) . LY341495 was found to prevent the A␤-mediated inhibition of LTP induction. In the presence of LY341495 (10 M) and A␤, LTP measured 192 Ϯ 14, 149 Ϯ 5, and 147 Ϯ 3% at peak, 20 min after HFS, and 60 min after HFS, respectively, with values significantly increased from the values in A␤ alone (n ϭ 5; p Ͻ 0.05) but not significantly different from control LTP ( p Ͼ 0.05) (Fig. 4 A) . The selective mGluR5 antagonist MPEP (5 M) (Gasparini et al., 1999 ) also prevented the A␤-mediated inhibition of LTP induction. In the presence of MPEP, LTP measured 192 Ϯ 15, 155 Ϯ 4, and 141 Ϯ 9% at peak, 20 min after HFS, and 60 min after HFS, respectively, with values significantly increased from LTP in A␤ alone (n ϭ 5; p Ͼ 0.01) but not significantly different from control LTP ( p Ͻ 0.05) (Fig. 4 B) .
In view of reports that A␤ has been found to bind to and activate ␣7 nAChR at picomolar concentrations (Dineley et al., 2001a,b) , the action of the selective ␣7 nAChR antagonist MLA was investigated regarding the ability of A␤ to inhibit LTP induction. MLA (1 M) did not prevent the A␤-mediated inhibition of LTP, with LTP measuring 154 Ϯ 11, 113 Ϯ 6, and 105 Ϯ 5% at peak, 20 min after HFS, and 60 min after HFS, respectively, and values were not significantly different from those in A␤ alone (n ϭ 5; p Ͼ 0.05) (Fig. 4 D) .
Discussion
In agreement with previous studies, we found that synthetic A␤ 1-42 has a strong inhibitory effect on the induction of hippocampal LTP (Cullen et al., 1997; Lambert et al., 1998; Itoh et al., 1999; Chen et al., 2000; Stephan et al., 2001; Vitolo et al., 2002) . In addition, we have also shown that cell-derived, naturally secreted A␤ inhibits LTP induction in vitro, extending our previous report on inhibition of LTP in CA1 in vivo (Walsh et al., 2002) . When solubilized in aqueous buffers, A␤ 1-42 assembles into a variety of structures, including low N-oligomers, ADDLs, protofibrils, and fibrils (Walsh et al., 1997; Lambert et al., 1998; Bitan et al., 2003) . The solutions of synthetic A␤ used in this study contain a mixture of these different assemblies. In contrast, the A␤ present in the cell-derived 7PA2 CM is free of fibrils and protofibrils and contained only A␤ monomers and soluble low N-oligomers (Walsh et al., 2002) . The finding that cell-derived A␤ inhibits LTP in vitro confirms that soluble assemblies of A␤ can inhibit LTP. Cell-derived, naturally secreted A␤ was much more potent than our synthetic A␤ preparation at inhibiting LTP induction. Thus, the threshold inhibitory concentration for cellderived A␤ was calculated to be ϳ0.7 nM, and that of synthetic A␤ was calculated to be between 100 and 200 nM (the values of the synthetic A␤ would be one-third lower than that stated if all batches of A␤ were identical to that determined; see Materials and Methods). The large difference in potency between cellderived and synthetic A␤ may be explained by only a very low concentration of biologically active oligomers of A␤ being present in the synthetic A␤ solution.
It is of interest that the very early phase of LTP, including initial peak amplitude measured at 1 min after HFS, was inhibited by cell-derived A␤ in the present in vitro studies. This demonstrates that binding of A␤ to a substrate affects a very early stage of LTP induction, such as the stimulation of kinases involved in LTP induction or early stages of increased AMPA receptor trafficking. In our previous studies in vivo, we had shown that cell-derived A␤ only inhibited LTP beginning ϳ1 hr after HFS. This difference between the in vitro and in vivo studies may be attributable to the longer period of pre-exposure to A␤ before HFS in vitro (60 min) compared with in vivo (10 min). Other possible explanations are a slower diffusion time of the A␤ after in vivo cannula injection compared with in vitro perfusion of A␤ or a concentration difference resulting from the fact that the A␤ injected in vivo is diluted by the CSF.
Few studies have explored the mechanisms underlying the A␤-mediated inhibition of LTP, although recently, one study found that A␤-mediated inhibition of LTP was reversed by rolipram and forskolin, drugs that enhance cAMP signaling (Vitolo et al., 2002 ). In the current study, we provide novel evidence that the A␤-evoked inhibition of LTP is mediated via activation of the kinases JNK, Cdk5, and p38 MAPK. There is previous evidence for the involvement of JNK in the neuropathology of AD. JNK activation has been described around amyloid deposits in AD brains (Anderson et al., 1994 (Anderson et al., , 1996 Shoji et al., 2000; Zhu et al., 2001a) , and synthetic A␤ activated the JNK pathway in various neuronal systems (Bozyczko-Coyne et al., 2001; Morishima et al., 2001; Troy et al., 2001) . Although A␤ increases expression of the stress-activated gene transcription factor c-Jun (Anderson et al., 1994; Estus et al., 1997) , such actions are likely to be too slow to account for the rapid inhibition of LTP by A␤ observed in the present study. Rather, a local synaptic action is more likely to be responsible for the effect of JNK inhibitors on the block of LTP. JNK activation is known to have a local cytoplasmic action leading to inhibition of dendritic growth (Coffey et al., 2000; Savage et al., 2002) , and it is possible that inhibition of LTP by A␤-mediated activation of JNK is an initial stage preceding such inhibition of dendritic growth.
The present evidence for involvement of p38 MAP kinase in the A␤-mediated inhibition of LTP parallels previous studies showing an increase in p38 MAP kinase activity affected by A␤ in cultured cells and also an increase in MAPK kinase 6, an upstream activator of p38, in susceptible neurons in AD brains (McDonald et al., 1998; Pyo et al., 1998) . Activation of JNK and p38 MAPK is likely to result in the inhibition of LTP via inflammatory pathways. A growing body of evidence suggests that A␤-mediated neurotoxicity involves the production of inflammatory cytokines such as tumor necrosis factor (TNF) and also free radicals and reactive oxygen species (Akama and Van Eldick, 2000) . In this regard, activation of JNK and p38 MAPK is known to have a pivotal role in TNF signaling and cell death (Paul et al., 1997) . The inhibition of LTP could be a very early indicator of the activation of inflammatory mediators. The A␤-mediated block of LTP was not prevented by the p42-p44 MAP kinase inhibitor U0126, demonstrating a lack of involvement of p42-p44 MAP kinases. In fact, p42-p44 MAP kinase is known to be required for the induction rather than inhibition of LTP and to be involved in cell survival rather than cell death (Sweatt, 2001 ).
The present finding that the Cdk5 inhibitors butyrolactone and roscovitine prevent the A␤-mediated inhibition of LTP parallels recent studies showing that Cdk inhibitors prevent A␤-induced neurotoxicity (Alvarez et al., 1999; Milton, 2001 ). Cdk5 has been postulated to have a major role in AD and A␤-induced neurodegeneration (Patrick et al., 1999; Ahlijanian et al., 2000) , with A␤ causing mislocalization and deregulation of Cdk5 by increasing production of its pathogenic activator p25 (Patrick et al., 1999; Lee et al., 2000; Town et al., 2002) .
The group I-II mGluR antagonist LY341495 and the mGluR5 antagonist MPEP were found to prevent the A␤-mediated inhibition of LTP, thus demonstrating the involvement of mGluR5 in the A␤-mediated inhibition of LTP. Selective antagonism of mGluR5 with MPEP has been shown previously to be neuroprotective against A␤ toxicity in cortical cultures (Bruno et al., 2000) , emphasizing the parallels between A␤-mediated inhibition of LTP and A␤-mediated neurotoxicity. In addition, the membrane depolarization evoked by relatively high concentrations of synthetic A␤ 1-42 was reported to involve activation of group I mGluRs (Blanchard et al., 2002) .
A model for A␤-mediated inhibition of LTP is proposed that involves activation of mGluRs and also the kinases JNK, Cdk5, and p38 MAPK. HFS is known to induce LTP via activation of NMDA receptors and influx of Ca 2ϩ . The inhibition of LTP is suggested to occur through a combination of the activation of an unidentified A␤ receptor(s) by A␤ and activation of mGluR5 by L-glutamate. Activation of mGluR5 could occur after L-glutamate is released from presynaptic terminals during HFS; mGluR5 is located perisynaptically on the postsynaptic cell and is known to be activated by spillover of glutamate during HFS. Alternatively, activation of mGluR5 could occur as a result of L-glutamate being released from glial cells, such as microglia after their activation by A␤. The combined activation of mGluR5 and the A␤ receptor(s) is suggested to stimulate JNK, Cdk5, and p38 MAPK. There is well documented evidence that A␤ stimulates these kinases, as described above, and recent work has shown that group I mGluR activation stimulates Cdk5 (Liu et al., 2001 ) and p38 MAP kinase (Bolshakov et al., 2000; Rush et al., 2002) . The requirement for combined activation of an A␤ receptor and mGluR5 may be necessary for sufficient stimulation of JNK, Cdk5, and p38 MAPK to produce inhibition of LTP. The mechanisms whereby these kinases inhibit LTP induction are unknown and are the subject of ongoing studies.
Antagonism of ␣7 nAChR did not prevent the A␤ block of LTP, demonstrating a lack of involvement of the ␣7 nAChR in A␤-mediated block of LTP in our paradigm. A␤ has been found to bind to and activate ␣7 nAChR at picomolar concentrations (Dineley et al., 2001a,b) . One possible reason for the lack of effect of blocking ␣7 nAChR on A␤-mediated inhibition of LTP is that ␣7 nAChRs have been found to be located only at high density on interneurons in the dentate gyrus and only at very low density on granule cells (Dobelis et al., 2002) .
In conclusion, our data demonstrate that A␤-mediated inhibition of LTP arises from activation of mGluR5 and stimulation of three kinases, JNKI, Cdk5, and p38 MAP kinase. Synaptic plasticity, and especially LTP, is known to be a critical component of the neural mechanisms underlying certain types of learning and memory (for review, see Morris et al., 2003) . Our study suggests that intervention using inhibitors of JNK, Cdk5, or p38 MAPK along with mGluR5 antagonists may turn out to ameliorate cognitive deficits in AD patients.
